| Physician burnout: contributors, consequences and solutions |
178 |
| Biomarkers for Alzheimer's disease: current status and prospects for the future |
66 |
| Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver |
40 |
| Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy |
35 |
| Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality |
33 |
| Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways |
28 |
| Diagnosis and treatment of primary aldosteronism: practical clinical perspectives |
28 |
| Clinical implications of bone marrow adiposity |
28 |
| Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial |
24 |
| Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management |
24 |
| Inflammation of brown/beige adipose tissues in obesity and metabolic disease |
23 |
| Smartphone-based clinical diagnostics: towards democratization of evidence-based health care |
22 |
| Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus |
20 |
| Treating osteoporosis to prevent fractures: current concepts and future developments |
20 |
| Amyloid fibril polymorphism: a challenge for molecular imaging and therapy |
19 |
| Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial |
19 |
| We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade |
18 |
| Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis |
18 |
| Type 2 diabetes mellitus and bone |
17 |
| The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey |
17 |
| Statins: a role in breast cancer therapy? |
16 |
| Current and emerging avenues for Alzheimer's disease drug targets |
16 |
| Biomarkers for heart failure: small molecules with high clinical relevance |
16 |
| Therapeutic value of stimulating the nitrate-nitrite-nitric oxide pathway to attenuate oxidative stress and restore nitric oxide bioavailability in cardiorenal disease |
15 |
| Manifestations and mechanisms of myocardial lipotoxicity in obesity |
15 |
| Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study |
15 |
| The Circadian Syndrome: is the Metabolic Syndrome and much more! |
15 |
| Mucus and mucins in diseases of the intestinal and respiratory tracts |
15 |
| Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts |
14 |
| eDoctor: machine learning and the future of medicine |
14 |
| Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents |
13 |
| Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics |
12 |
| Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation |
12 |
| Vitamin D and tuberculosis: where next? |
12 |
| Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma |
12 |
| Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study |
11 |
| Metabolomic response to coffee consumption: application to a three-stage clinical trial |
11 |
| Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial |
11 |
| Genes that make you fat, but keep you healthy |
11 |
| Exercise counteracts lipotoxicity by improving lipid turnover and lipid droplet quality |
11 |
| Reduced plasma PCSK9 response in patients with bacteraemia is associated with mortality |
10 |
| The challenges and possibilities of public access defibrillation |
10 |
| Health consequences of androgenic anabolic steroid use |
10 |
| Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia |
10 |
| Rapidly developing multimorbidity and disability in older adults: does social background matter? |
10 |
| Peptide-based multi-agonists: a new paradigm in metabolic pharmacology |
9 |
| Conservative management in hypertriglyceridemia-associated pancreatitis |
9 |
| The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence |
9 |
| Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases |
9 |
| FDG-PET/CT in the management of lymphomas: current status and future directions |
9 |
